VolitionRx Ltd
VNRX
47 hedge funds and large institutions have $22M invested in VolitionRx Ltd in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 11 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0.02% more ownership
Funds ownership: 0.7% → 0.71% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $25M → $22M (-$3.01M)
15% less funds holding
Funds holding: 55 → 47 (-8)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$649K |
| 2 |
LIM
Lagoda Investment Management
New York
|
+$644K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$385K |
| 4 |
BlackRock
New York
|
+$275K |
| 5 |
Morgan Stanley
New York
|
+$116K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$175K |
| 2 |
CPA
Cowen Prime Advisors
New York
|
-$155K |
| 3 |
Jane Street
New York
|
-$128K |
| 4 |
Renaissance Technologies
New York
|
-$112K |
| 5 |
Squarepoint
New York
|
-$99K |
VNRX Hedge Fund Activity: Q3 2020 in Review
47 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2020, worth a combined $22M — down 12% from $25M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of VNRX and 4 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 15 added.
The largest buyer was Northern Trust, adding an estimated $649K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $175K sold.
- 47 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2020, down from 55 in Q2 2020.
- Funds reported $22M of VolitionRx Ltd stock for Q3 2020, down 12% quarter-over-quarter.
- 4 funds opened new VolitionRx Ltd positions in Q3 2020 and 11 closed out, a net change of -7 holders.
- The largest VolitionRx Ltd buyer in Q3 2020 was Northern Trust, an estimated $649K added.
- The largest VolitionRx Ltd seller in Q3 2020 was Two Sigma Investments, an estimated $175K sold.
Based on aggregated 13F filings for Q3 2020.